Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Bloomios Inc - SIC # 2833 - MEDICINAL CHEMICALS AND BOTANICAL PRODUCTS
Ticker
Exchange
SIC #
Website
Latest Ticker
BLMS
Over the counter
2833
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Bloomios Inc
Bloomios Completes $23.5 Million Acquisition of Leading Gummy Manufacturer
- Oct 27th, 2022 12:31 pm
Upexi Announces Sale of Select CBD Assets for $23.5 Million
- Oct 27th, 2022 12:30 pm
Bloomios To Present at The 2022 LD Micro Main Event October 25-27
- Oct 20th, 2022 7:00 pm
Bloomios to Develop and Produce New Range of Private-Label Products Utilizing, Ashwagandha, Melatonin, Kratom, Lion's Mane, Valerian Root, Reishi Mushroom and other Natural Ingredients
- Aug 4th, 2022 8:44 pm
Bloomios to Present at the 2022 LD Micro Invitational June 7-9
- May 25th, 2022 12:31 pm
Bloomios Expands Production Capacity by 300%, Setting Stage for Strong Growth in 2022
- May 18th, 2022 12:31 pm
Bloomios Reports 2021 Revenue at Record $8.5 Million, up from $1.3 Million in 2020
- Apr 19th, 2022 12:31 pm
Bloomios Selected as Exclusive Manufacturer for DRYWORLD's New Athletic Performance CBD Product Line
- Mar 31st, 2022 8:40 pm
DRYWORLD Struts into Multi-Billion Dollar CBD Market
- Mar 31st, 2022 8:20 pm
Scroll